Total Payments
$910.05
2024 Payments
$32.67
Companies
20
Transactions
52
Medicare Patients
52,217
Medicare Billing
$2.6M
Payment Breakdown by Category
Food & Beverage$895.15 (98.4%)
Education$14.90 (1.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $895.15 | 51 | 98.4% |
| Education | $14.90 | 1 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $171.45 | 9 | $0 (2022) |
| PFIZER INC. | $133.00 | 7 | $0 (2020) |
| Lilly USA, LLC | $94.85 | 6 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $77.51 | 4 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $56.20 | 4 | $0 (2019) |
| Amgen Inc. | $45.00 | 2 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $42.88 | 3 | $0 (2020) |
| Boston Scientific Corporation | $32.67 | 1 | $0 (2024) |
| Novo Nordisk Inc | $31.91 | 2 | $0 (2018) |
| Allergan, Inc. | $30.19 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $32.67 | 1 | Boston Scientific Corporation ($32.67) |
| 2023 | $15.29 | 1 | AcelRx Pharmaceuticals, Inc. ($15.29) |
| 2022 | $16.54 | 1 | GlaxoSmithKline, LLC. ($16.54) |
| 2021 | $112.57 | 6 | GlaxoSmithKline, LLC. ($37.22) |
| 2020 | $90.27 | 6 | Allergan, Inc. ($30.19) |
| 2019 | $236.03 | 13 | GlaxoSmithKline, LLC. ($75.72) |
| 2018 | $261.69 | 16 | PFIZER INC. ($74.85) |
| 2017 | $144.99 | 8 | Lilly USA, LLC ($32.99) |
All Payment Transactions
52 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/18/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $32.67 | General |
| Category: General - Pain Management_NMD | ||||||
| 02/23/2023 | AcelRx Pharmaceuticals, Inc. | Dsuvia (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Pain Management | ||||||
| 05/05/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: VACCINES | ||||||
| 12/08/2021 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Neuroscience | ||||||
| 09/22/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/08/2021 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: IMMUNOLOGY | ||||||
| 07/28/2021 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $20.54 | General |
| Category: Neuroscience | ||||||
| 06/11/2021 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: VACCINES | ||||||
| 03/05/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: RESPIRATORY | ||||||
| 07/21/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: RESPIRATORY | ||||||
| 02/18/2020 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 01/31/2020 | Allergan, Inc. | BOTOX COSMETIC (Biological) | Food and Beverage | In-kind items and services | $15.27 | General |
| 01/23/2020 | Allergan, Inc. | BOTOX COSMETIC (Biological) | Food and Beverage | In-kind items and services | $14.92 | General |
| 01/22/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Respiratory | ||||||
| 01/08/2020 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Diabetes | ||||||
| 12/18/2019 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: VACCINES | ||||||
| 10/01/2019 | GlaxoSmithKline, LLC. | ANORO (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: RESPIRATORY | ||||||
| 09/24/2019 | Avion Pharmaceuticals | Prenate Mini (Drug), FaLessa | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: Prenatal vitamin | ||||||
| 08/27/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: RESPIRATORY | ||||||
| 08/27/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Education | In-kind items and services | $14.90 | General |
| Category: RESPIRATORY | ||||||
| 08/22/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.42 | General |
| 06/25/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: RESPIRATORY | ||||||
| 05/23/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 05/21/2019 | GlaxoSmithKline, LLC. | BEXSERO (Biological), SHINGRIX | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: VACCINES | ||||||
| 05/15/2019 | Avion Pharmaceuticals | Prenate Mini (Drug), FaLessa | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Prenatal vitamin | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 82 | 15,702 | 22,123 | $2.5M | $722,894 |
| 2022 | 94 | 15,620 | 21,737 | $2.2M | $729,825 |
| 2021 | 83 | 13,537 | 19,340 | $1.9M | $706,290 |
| 2020 | 73 | 7,358 | 10,982 | $1.5M | $490,218 |
Total Patients
52,217
Total Services
74,182
Medicare Billing
$2.6M
Procedure Codes
332
All Medicare Procedures & Services
332 procedure records from CMS Medicare Utilization — Page 1 of 14
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 1,038 | 2,248 | $730,600 | $205,198 | 28.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 936 | 1,523 | $380,750 | $90,380 | 23.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 549 | 549 | $137,250 | $72,386 | 52.7% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 1,291 | 1,626 | $90,014 | $26,764 | 29.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 1,277 | 1,566 | $70,721 | $20,546 | 29.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 126 | 142 | $65,500 | $19,513 | 29.8% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 122 | 240 | $44,670 | $16,989 | 38.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 211 | 248 | $57,759 | $16,974 | 29.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 1,407 | 2,117 | $59,934 | $16,110 | 26.9% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2023 | 149 | 171 | $46,173 | $15,883 | 34.4% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 1,275 | 1,824 | $55,402 | $15,121 | 27.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 112 | 141 | $45,825 | $11,366 | 24.8% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 187 | 220 | $28,200 | $10,972 | 38.9% |
| 80076 | Liver function blood test panel | Office | 2023 | 1,107 | 1,339 | $39,494 | $10,725 | 27.2% |
| 82306 | Vitamin d-3 level | Office | 2023 | 305 | 364 | $32,323 | $10,560 | 32.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 187 | 229 | $57,250 | $9,202 | 16.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 525 | 757 | $27,797 | $7,835 | 28.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 45 | 46 | $17,250 | $7,753 | 44.9% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 397 | 504 | $25,321 | $7,449 | 29.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 30 | 31 | $15,362 | $6,590 | 42.9% |
| 82746 | Folic acid level, serum | Office | 2023 | 358 | 440 | $21,604 | $6,340 | 29.3% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 27 | 27 | $18,423 | $6,179 | 33.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 57 | 58 | $17,400 | $5,847 | 33.6% |
| 99493 | Follow-up psychiatric collaborative care management, subsequent calendar month, first 60 minutes | Office | 2023 | 17 | 50 | $12,500 | $5,673 | 45.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 425 | 589 | $19,482 | $5,607 | 28.8% |
About Dr. Mark Allara, MD
Dr. Mark Allara, MD is a Family Medicine healthcare provider based in Danvers, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659457984.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Allara, MD has received a total of $910.05 in payments from pharmaceutical and medical device companies, with $32.67 received in 2024. These payments were reported across 52 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($895.15).
As a Medicare-enrolled provider, Allara has provided services to 52,217 Medicare beneficiaries, totaling 74,182 services with total Medicare billing of $2.6M. Data is available for 4 years (2020–2023), covering 332 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Danvers, MA
- Active Since 10/30/2006
- Last Updated 12/02/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1659457984
Products in Payments
- CHANTIX (Drug) $86.54
- TRULICITY (Drug) $81.70
- Trintellix (Drug) $80.60
- SPIRIVA RESPIMAT (Drug) $77.51
- SHINGRIX (Biological) $58.88
- PREVNAR - 13 (Biological) $46.46
- Prolia (Biological) $45.00
- BEXSERO (Biological) $38.62
- TRELEGY ELLIPTA (Drug) $36.40
- BOTOX COSMETIC (Biological) $30.19
- BEVESPI AEROSPHERE (Drug) $28.75
- Prenate Mini (Drug) $25.16
- SYNTHROID (Drug) $23.38
- Aptima Trich (Device) $22.92
- BOOSTRIX (Biological) $21.64
- ZEPOSIA (Drug) $20.54
- ENTRESTO (Drug) $18.28
- Victoza (Drug) $17.73
- MYDAYIS (Drug) $17.40
- ANORO (Drug) $15.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Danvers
Matthew Plosker, M.d, M.D
Family Medicine — Payments: $1,242
Family Medicine $1,242
Meghan Tramontozzi, Md, MD
Family Medicine — Payments: $780.22
Family Medicine $780.22
Dr. Michael Yoon, M.d, M.D
Family Medicine — Payments: $628.10
Family Medicine $628.10
Dr. Brent Fryling, M.d, M.D
Family Medicine — Payments: $598.96
Family Medicine $598.96
Dana Mann, M.d, M.D
Family Medicine — Payments: $157.42
Family Medicine $157.42
Leonard Horowitz, M.d, M.D
Family Medicine — Payments: $17.12
Family Medicine $17.12